An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria

Lal Vijayalal S;Arora S;Dabas R;Janney MS;Jankal Basavarajappa S;Das NM;;
dermatologic therapy 2020 pp. -
120
s2020dermatologican

Abstract

Chronic Spontaneous Urticaria (CSU) is one of the most challenging therapeutic problems faced by dermatologists. Omalizumab is a third line drug for CSU which is currently recommended as monthly injections for 6 months. To study the efficacy of single injection of Omalizumab in the treatment of CSU. …

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:33040395 doi:10.1111/dth.14397 sandeep lal vijayalal sandeep arora niyor m das

Access

URL:
http://www.ncbi.nlm.nih.gov/pubmed/33040395

Citation

ID: 261731
Ref Key: s2020dermatologican
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
261731
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store